Help
Translations:Ipragliflozin/8/ja: Difference between revisions
From Azupedia
Jump to navigation
Jump to search
Visual
Wikitext
Latest revision as of 21:09, 20 February 2024
view source
Fire
(
talk
|
contribs
)
Bureaucrats
,
Interface administrators
,
Administrators
149,888
edits
Created page with "==臨床試験== {{Anchor|Clinical trials}} イプラグリフロジンの有効性及び安全性は、国内における
フェーズⅢ
の単剤投与試験及び他の血糖降下剤（6種類）との併用臨床試験において確認されている。"
(No difference)
Latest revision as of 21:09, 20 February 2024
Information about message (
contribute
)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (
Ipragliflozin
)
==Clinical trials==
The efficacy and safety of ipragliflozin were both observed in a [[Phases of clinical research#Phase III|Phase III]] study in monotherapy and clinical studies used in combination with other hypoglycemic agents (6 types) in Japan.
臨床試験
イプラグリフロジンの有効性及び安全性は、国内における
フェーズⅢ
の単剤投与試験及び他の血糖降下剤（6種類）との併用臨床試験において確認されている。
Navigation menu
Personal tools
English
Log in
Namespaces
Translation unit
Discussion
日本語
Views
Read
View source
View history
More
Search
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Printable version
Permanent link
Page information
In other languages
LINK
投資用語集
The Motley Fool
Wikipedia ja
Wikipedia en
Create Item
Create Property
In other projects
In other languages
Add links